Loading...

Bristol-Myers Squibb Company

BMYNYSE
Healthcare
Drug Manufacturers - General
$48.43
$-0.51(-1.04%)

Bristol-Myers Squibb Company (BMY) Stock Competitors & Peer Comparison

See (BMY) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BMY$48.43-1.04%98.6B18.08$2.68+5.09%
LLY$812.69+0.90%770.4B65.98$12.32+0.69%
JNJ$168.30-0.74%405B18.02$9.34+2.98%
ABBV$190.28-0.29%336.2B81.35$2.34+3.39%
NVO$71.70+1.37%317.7B19.44$3.69+2.25%
NVS$117.70+0.20%229B17.15$6.86+3.40%
AZN$72.66-1.38%225.3B29.29$2.48+2.12%
MRK$84.71+0.71%212.8B12.32$6.88+3.76%
AMGN$306.58-0.64%164.8B27.92$10.98+3.02%
GILD$116.20+2.65%144.5B15.01$7.74+2.68%
Showing 1 to 10 of 24 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BMY vs LLY Comparison July 2025

BMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BMY stands at 98.6B. In comparison, LLY has a market cap of 770.4B. Regarding current trading prices, BMY is priced at $48.43, while LLY trades at $812.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BMY currently has a P/E ratio of 18.08, whereas LLY's P/E ratio is 65.98. In terms of profitability, BMY's ROE is +0.32%, compared to LLY's ROE of +0.77%. Regarding short-term risk, BMY is more volatile compared to LLY. This indicates potentially higher risk in terms of short-term price fluctuations for BMY.Check LLY's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;